Access the full text.
Sign up today, get DeepDyve free for 14 days.
X. Pourrat, D. Antier, Isabelle Crenn, G. Calais, A. Jonville‐Béra, A. Rouleau (2004)
A prescription and administration error of cisplatin: a case reportPharmacy World and Science, 26
L. Kovacic, C. Chambers (2011)
Look-alike, sound-alike drugs in oncologyJournal of Oncology Pharmacy Practice, 17
B. Zernikow, E. Michel, G. Fleischhack, U. Bode (1999)
Accidental Iatrogenic Intoxications by Cytotoxic DrugsDrug Safety, 21
L. Schulmeister (2006)
Look-alike, sound-alike oncology medications.Clinical journal of oncology nursing, 10 1
K. Walsh, K. Dodd, K. Seetharaman, D. Roblin, L. Herrinton, A. Worley, G. Usmani, D. Baer, J. Gurwitz (2009)
Medication errors among adults and children with cancer in the outpatient setting.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 6
T. Gandhi, S. Bartel, L. Shulman, Deborah Verrier, E. Burdick, A. Cleary, J. Rothschild, L. Leape, D. Bates (2005)
Medication safety in the ambulatory chemotherapy settingCancer, 104
R. Liem, M. Higman, Allen Chen, R. Arceci (2003)
Misinterpretation of a Calvert-derived formula leading to carboplatin overdose in two children.Journal of pediatric hematology/oncology, 25 10
(1998)
A review of the national chemotherapy errors database and recommendations for safe administration
B. Erdlenbruch, M. Lakomek, L. Bjerre (2002)
Chemotherapy errors in oncologyMedical and Pediatric Oncology, 38
A. Fyhr (2011)
Compilation of lex Maria- and HSAN-cases, parenteral cytotoxic drugs, 1996-2008, Swedish cases.
T. Lesar (2002)
Tenfold Medication Dose Prescribing ErrorsAnnals of Pharmacotherapy, 36
B. Erdlenbruch, M. Lakomek, L. Bjerre (2002)
Editorial: chemotherapy errors in oncology.Medical and pediatric oncology, 38 5
D. Schwappach, M. Wernli (2010)
Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature.European journal of cancer care, 19 3
L. Schulmeister (2008)
Patient misidentification in oncology care.Clinical journal of oncology nursing, 12 3
(2010)
Cancerfondsrapporten (Report from The Swedish Cancer Society -in Swedish)
B. O'neal, John Worden, R. Couldry (2009)
Telepharmacy and bar-code technology in an i.v. chemotherapy admixture area.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 66 13
E. Vila-Torres, A. Albert-Marí, D. Almenar-Cubells, N. Jimenez-Torres (2009)
Cisplatin preparation error; patient management and morbidityJournal of Oncology Pharmacy Practice, 15
(1998)
National Coordinating Council for Medication Error Reporting and Prevention (2011) Types of Medication Errors
J. Phillips, Sammie Beam, A. Brinker, C. Holquist, Peter Honig, Laureen Lee, C. Pamer (2001)
Retrospective analysis of mortalities associated with medication errors.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 58 19
A. Greenberg, S. Kramer, Vickie Welch, E. O'sullivan, S. Hall (2006)
Cancer Care Ontario's computerized physician order entry system: a province-wide patient safety innovation.Healthcare quarterly, 9 Spec No
R. Ferner, J. Aronson (2006)
Clarification of terminology in medication errors: definitions and classification.Drug safety, 29 11
M. Rinke, A. Shore, L. Morlock, R. Hicks, Marlene Miller (2007)
Characteristics of pediatric chemotherapy medication errors in a national error reporting databaseCancer, 110
FYHR A. & AKSELSSON R. (2012) European Journal of Cancer Care21, 606–613 Characteristics of medication errors with parenteral cytotoxic drugs Errors involving cytotoxic drugs have the potential of being fatal and should therefore be prevented. The objective of this article is to identify the characteristics of medication errors involving parenteral cytotoxic drugs in Sweden. A total of 60 cases reported to the national error reporting systems from 1996 to 2008 were reviewed. Classification was made to identify cytotoxic drugs involved, type of error, where the error occurred, error detection mechanism, and consequences for the patient. The most commonly involved cytotoxic drugs were fluorouracil, carboplatin, cytarabine and doxorubicin. The platinum‐containing drugs often caused serious consequences for the patients. The most common error type were too high doses (45%) followed by wrong drug (30%). Twenty‐five of the medication errors (42%) occurred when doctors were prescribing. All of the preparations were delivered to the patient causing temporary or life‐threatening harm. Another 25 of the medication errors (42%) started with preparation at the pharmacies. The remaining 10 medication errors (16%) were due to errors during preparation by nurses (5/60) and administration by nurses to the wrong patient (5/60). It is of utmost importance to minimise the potential for errors in the prescribing stage. The identification of drugs and patients should also be improved.
European Journal of Cancer Care – Wiley
Published: Sep 1, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.